Taiyen assures on supply of nonradioactive salt -
| 1737 Stock | TWD 32.20 0.05 0.16% |
Slightly above 62% of Taiyen Biotech's investor base is looking to short. The analysis of current outlook of investing in Taiyen Biotech Co suggests that many traders are alarmed regarding Taiyen Biotech's prospects. Taiyen Biotech's investing sentiment can be driven by a variety of factors including economic data, Taiyen Biotech's earnings reports, geopolitical events, and overall market trends.
Taiyen Biotech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Taiyen daily returns and investor perception about the current price of Taiyen Biotech Co as well as its diversification or hedging effects on your existing portfolios.
Taiyen |
Taiyen assures on supply of nonradioactive salt
Read at news.google.com
 |
Taiyen Biotech Fundamental Analysis
We analyze Taiyen Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Taiyen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Taiyen Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Taiyen Biotech is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Taiyen Biotech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Taiyen Biotech stock to make a market-neutral strategy. Peer analysis of Taiyen Biotech could also be used in its relative valuation, which is a method of valuing Taiyen Biotech by comparing valuation metrics with similar companies.
Peers
Taiyen Biotech Related Equities
| 1464 | De Licacy | 1.30 | ||||
| 1465 | Wisher Industrial | 0.68 | ||||
| 1473 | Tainan Enterprises | 1.80 |
Additional Tools for Taiyen Stock Analysis
When running Taiyen Biotech's price analysis, check to measure Taiyen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taiyen Biotech is operating at the current time. Most of Taiyen Biotech's value examination focuses on studying past and present price action to predict the probability of Taiyen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taiyen Biotech's price. Additionally, you may evaluate how the addition of Taiyen Biotech to your portfolios can decrease your overall portfolio volatility.